Thomas Ulich
2016
In 2016, Thomas Ulich earned a total compensation of $463.3K as Chief Scientific Officer at InVivo Therapeutics Holdings, a 62% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $77,997 |
|---|---|
| Salary | $336,375 |
| Other | $48,907 |
| Total | $463,279 |
Ulich received $336.4K in salary, accounting for 73% of the total pay in 2016.
Ulich also received $78K in non-equity incentive plan and $48.9K in other compensation.
Rankings
In 2016, Thomas Ulich's compensation ranked 11,439th out of 14,075 executives tracked by ExecPay. In other words, Ulich earned more than 18.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,439 out of 14,075 | 19th |
Division Manufacturing | 4,457 out of 5,489 | 19th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 604 out of 827 | 27th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 360 out of 510 | 29th |
Industry Surgical and Medical Instruments and Apparatus | 219 out of 313 | 30th |
Source: SEC filing on April 25, 2017.
Ulich's colleagues
We found six more compensation records of executives who worked with Thomas Ulich at InVivo Therapeutics Holdings in 2016.
2016
Pamela Stahl
InVivo Therapeutics Holdings
Chief Commercial Officer
2016
Mark Perrin
InVivo Therapeutics Holdings
Chief Executive Officer
2016
Christopher McNulty
InVivo Therapeutics Holdings
Chief Financial Officer
2016
Lorianne Masuoka
InVivo Therapeutics Holdings
Chief Medical Officer
2016
Steven McAllister
InVivo Therapeutics Holdings
Chief Financial Officer
2016
Tamara Joseph
InVivo Therapeutics Holdings